UnitedHealth Group’s (NYSE: UNH) subsidiary Optum, which holds a substantial home health and hospice business, continues to be a major driver of the company’s growth. Optum is in the process of acquiring the home health and hospice provider Amedisys (NASDAQ: AMED), with closing expected before the end of the year, pending some regulatory hurdles. Optum […]
Despite intensifying regulatory scrutiny on its deals, UnitedHealth Group (NYSE: UNH) remains poised for further acquisitions. During the past two years, the insurance giant has completed a slew of acquisitions spanning much of the health care continuum — including hospice, palliative care and home health — as well as health care technology, largely through its […]
In case you missed it, Hospice News has launched a new specialty publication for palliative care professionals. You can subscribe to Palliative Care News here: Subscribe today! The U.S. Justice Department is investigating UnitedHealth Group (NYSE: UNH) due to antitrust concerns. During the past two years, the insurance giant has completed a slew of acquisitions […]
Optum Health’s home-based care acquisitions are designed to support an overarching goal of expanding value-based care and diversifying clinical capabilities. The UnitedHealth Group (NYSE: UNH) subsidiary in June penned an agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. This followed its $5.4 billion acquisition of LHC Group, […]
Sen. Elizabeth Warren (D-Massachusetts) and Rep. Pramila Jayapal (D-Washington) have called on the U.S. Justice Department (DOJ) and the Federal Trade Commission (FTC) to “scrutinize” the pending acquisition of Amedisys (NASDAQ: AMED) by Optum Health. Optum, a subsidiary of UnitedHealth Group (NYSE: UHN), in June penned its agreement to acquire Amedisys in an all-cash transaction […]
The U.S. Department of Justice (DOJ) will investigate potential antitrust violations in the UnitedHealth Group (NYSE: UNH) subsidiary Optum’s forthcoming acquisition of Amedisys, Inc. (NASDAQ: AMED). To date, neither Amedisys nor Optum have been accused of any wrongdoing. The DOJ performed a similar investigation when Optum acquired the health care technology company Change Healthcare earlier this […]
UnitedHealth Group (NYSE: UNH) subsidiary Optum Health recently tapped Dr. Amar Desai as its new CEO. The change in leadership comes on the heels of Optum Health’s growing presence in the hospice and home health landscape. The company has acquired two of the nation’s largest providers — LHC Group and Amedisys Inc. (NASDAQ: AMED) — […]
The hospice space — and the health care system at large — is in a state of flux, driven by value-based reimbursement models, an expanding home-based care continuum and industry-changing transactions. Halfway through the year, Hospice News’ “Four Providers to Watch,” exemplifies the ways that hospice operators are trying to not only to keep up […]
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]
The anticipated acquisition of LHC Group (NASDAQ: LHCG) by the UnitedHealth Group (NYSE: UNH) subsidiary Optum is now expected to close during the first quarter of 2023. Optum in April announced its agreement to purchase the Lafayette, Louisiana-based home health and hospice provider for $5.5 billion. Initially expected to close this year, LHC Group today […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
